Avner Ramu

787 total citations
24 papers, 676 citations indexed

About

Avner Ramu is a scholar working on Oncology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Avner Ramu has authored 24 papers receiving a total of 676 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 13 papers in Molecular Biology and 4 papers in Organic Chemistry. Recurrent topics in Avner Ramu's work include Drug Transport and Resistance Mechanisms (8 papers), Metal complexes synthesis and properties (3 papers) and Photodynamic Therapy Research Studies (3 papers). Avner Ramu is often cited by papers focused on Drug Transport and Resistance Mechanisms (8 papers), Metal complexes synthesis and properties (3 papers) and Photodynamic Therapy Research Studies (3 papers). Avner Ramu collaborates with scholars based in Israel, United States and Portugal. Avner Ramu's co-authors include Nili Ramu, Leming Shi, Gilles Klopman, Luı́s M. Rosário, Harvey B. Pollard, Dan Gibson, Mira Korner, Alberto Gabizon, Yechezkel Barenholz and Israel Ringel and has published in prestigious journals such as Journal of Medicinal Chemistry, International Journal of Cancer and Biochemical Pharmacology.

In The Last Decade

Avner Ramu

24 papers receiving 649 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Avner Ramu Israel	14	364	335	120	89	72	24	676
Milena Salerno France	21	432 1.2×	400 1.2×	95 0.8×	133 1.5×	80 1.1×	37	898
Olafur Gudmundsson United States	15	296 0.8×	231 0.7×	55 0.5×	51 0.6×	99 1.4×	24	724
Anand Balakrishnan United States	20	458 1.3×	345 1.0×	102 0.8×	122 1.4×	190 2.6×	36	1.2k
Anders Buur Denmark	19	224 0.6×	286 0.9×	179 1.5×	32 0.4×	22 0.3×	36	829
Hamish Ryder Spain	20	244 0.7×	528 1.6×	446 3.7×	85 1.0×	68 0.9×	46	1.2k
Linda L. Lien United States	11	162 0.4×	396 1.2×	59 0.5×	34 0.4×	54 0.8×	22	717
Serena Scapecchi Italy	20	423 1.2×	750 2.2×	456 3.8×	165 1.9×	67 0.9×	82	1.3k
Kevin N. Dack United Kingdom	12	99 0.3×	260 0.8×	221 1.8×	48 0.5×	25 0.3×	22	683
Heiner Glombik Germany	15	312 0.9×	344 1.0×	134 1.1×	45 0.5×	69 1.0×	24	713
Robert A. Carr United States	19	191 0.5×	193 0.6×	39 0.3×	28 0.3×	70 1.0×	41	986

Countries citing papers authored by Avner Ramu

Since Specialization

Citations

This map shows the geographic impact of Avner Ramu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Avner Ramu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Avner Ramu more than expected).

Fields of papers citing papers by Avner Ramu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Avner Ramu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Avner Ramu. The network helps show where Avner Ramu may publish in the future.

Co-authorship network of co-authors of Avner Ramu

This figure shows the co-authorship network connecting the top 25 collaborators of Avner Ramu. A scholar is included among the top collaborators of Avner Ramu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Avner Ramu. Avner Ramu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Ramu, Avner, et al.. (2001). The enhancement of riboflavin-mediated photo-oxidation of doxorubicin by histidine and urocanic acid. Cancer Chemotherapy and Pharmacology. 47(4). 338–346. 10 indexed citations

2.

Ramu, Avner, et al.. (2000). The riboflavin-mediated photooxidation of doxorubicin. Cancer Chemotherapy and Pharmacology. 46(6). 449–458. 42 indexed citations

3.

Ramu, Avner, et al.. (1999). Reduced UV-Induced Degradation of Doxorubicin Encapsulated in Polyethyleneglycol-Coated Liposomes. Pharmaceutical Research. 16(6). 841–846. 44 indexed citations

4.

Bomgaars, Lisa, Sriya Gunawardena, Shannon E. Kelley, & Avner Ramu. (1997). The inactivation of doxorubicin by long ultraviolet light. Cancer Chemotherapy and Pharmacology. 40(6). 506–512. 15 indexed citations

5.

Klopman, Gilles, Leming Shi, & Avner Ramu. (1997). Quantitative Structure-Activity Relationship of Multidrug Resistance Reversal Agents. Molecular Pharmacology. 52(2). 323–334. 119 indexed citations

6.

Ramu, Avner & Nili Ramu. (1994). Reversal of multidrug resistance by bis(phenylalkyl)amines and structurally related compounds. Cancer Chemotherapy and Pharmacology. 34(5). 423–430. 21 indexed citations

7.

Ramu, Avner & Nili Ramu. (1994). Reversal of multidrug resistance by bis(phenylalkyl)amines and structurally related compounds. Cancer Chemotherapy and Pharmacology. 34(5). 423–430. 3 indexed citations

8.

Ramu, Avner & Nili Ramu. (1993). Resistance to Lipophilic Cationic Compounds in Multidrug Resistant Leukemia Cells. Leukemia & lymphoma. 9(3). 247–253. 7 indexed citations

9.

Ramu, Avner & Nili Ramu. (1992). Reversal of multidrug resistance by phenothiazines and structurally related compounds. Cancer Chemotherapy and Pharmacology. 30(3). 165–173. 99 indexed citations

10.

Blum, Jochanan, et al.. (1992). Preparation, characterization and antileukemic properties of diaminemalonatoplatinum(II) complexes tethered to ferrocene. Inorganica Chimica Acta. 201(2). 219–221. 17 indexed citations

11.

Ramu, Avner, Nili Ramu, & Raphael Gorodetsky. (1991). Reduced ouabain-sensitive potassium entry as a possible mechanism of multidrug-resistance in P388 cells. Biochemical Pharmacology. 42(9). 1699–1704. 10 indexed citations

12.

Gibson, Dan, et al.. (1991). Preparation, characterization, and anticancer activity of a series of cis-PtCl2 complexes linked to anthraquinone intercalators. Journal of Medicinal Chemistry. 34(1). 414–420. 57 indexed citations

13.

Ramu, Avner, Nili Ramu, & Luı́s M. Rosário. (1991). Circumvention of multidrug-resistance in P388 cells is associated with a rise in the cellular content of phosphatidylcholine. Biochemical Pharmacology. 41(10). 1455–1461. 22 indexed citations

14.

Ramu, Avner, Harvey B. Pollard, & Luı́s M. Rosário. (1989). Doxorubicin resistance in P388 leukemia—evidence for reduced drug influx. International Journal of Cancer. 44(3). 539–547. 62 indexed citations

15.

Ramu, Nili & Avner Ramu. (1989). Circumvention of adriamycin resistance by dipyridamole analogues: A structure‐activity relationship study. International Journal of Cancer. 43(3). 487–491. 43 indexed citations

16.

Ramu, Avner, Boris Yagen, & Nili Ramu. (1989). The cytotoxicity of T-2 toxin and related 12,13-epoxytrichothecenes to Adriamycin-sensitive and-resistant P388 leukemia cells. Cancer Chemotherapy and Pharmacology. 24(4). 264–7. 5 indexed citations

17.

Ringel, Israel, et al.. (1988). N-Alkyl colchiceineamides: their inhibition of GTP or taxol-induced assembly of tubulin. Biochemical Pharmacology. 37(12). 2487–2489. 9 indexed citations

18.

Ramu, Avner, et al.. (1985). Cross resistance to esters of methotrexate in a doxorubicin-resistant subline of P388 murine leukemia. Cancer Chemotherapy and Pharmacology. 15(1). 31–4. 6 indexed citations

19.

Pollard, Harvey B., Christopher J. Pazoles, Carl E. Creutz, et al.. (1977). A role for anion transport in the regulation of release from chromaffin granules and exocytosis from cells. Journal of Supramolecular Structure. 7(3-4). 277–285. 29 indexed citations

20.

Ramu, Avner & Felix Bergmann. (1972). The effects of pentobarbitone and cerebellectomy on blood-pressure changes evoked by stimulation of the central end of the cut vagus of the rabbit. European Journal of Pharmacology. 19(2). 160–164. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact